PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.\', \'Division of Virology, Department of Veterinary Sciences, German Center for Infection Research, 80539 Munich, Germany.\', \'Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.\', \'Institute of Virology, Marburg, German Center for Infection Research, 35392 Giessen-Marburg-Langen, Germany.\', \'Department of Viroscience, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.\', \'Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.\', \'Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians-Universität München, 80804 Munich, Germany.\', \'Institute of Immunology, German Center for Infection Research, 30625 Hannover, Germany.\', \'Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, 30625 Hannover, Germany.\', \'Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany; gerd.sutter@lmu.de.\', \'Institute of Virology, University of Veterinary Medicine, Hannover, 30559 Hannover, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • e202620711810.1073/pnas.2026207118
?:doi
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 34162739
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
?:title
  • Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all